A Multi-center, Randomized, Double-blind, Placebo control, Therapeutic Confirmatory, Phase III Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation